Shaking off shingles with nanoviricides

NanoViricides, Inc. has developed unique micelles termed nanoviricides that can bind and inactivate viruses, including those that cause shingles and genital ulcers.

Like 3 Comment
Page of
Go to the profile of NanoViricides


NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". Virus-specific nanoviricide drug candidates against five commercially important viral diseases, viz. seasonal and potentially-epidemic influenzas and bird flu, HIV/AIDS, cold sores and genital herpes infection, viral eye diseases, as well as dengue viruses, have demonstrated very high levels of effectiveness.

No comments yet.